Study on bisphosphonate-related osteonecrosis of the jaw (BRONJ): case report and literature review

키워드

참고문헌 (54)

1. Marx RE, "Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic", J Oral Maxillofac Surg, 61, pp.1115~1117 (2003)
2. Marx RE, "Biphosphonateinduced exposed bone (osteonecrosis", ostoepetrosis) of the jaws: risk factors, recognition, prevention, and treatment, 2005, pp.63, 1567~1575
3. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, "American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws", J Oral Maxillofac Surg, 65, pp.369~376 (2007)
4. 권용대, "Bisphosphonate, 구강악안면외과 영역의 새로운 위험 요소인가?", 대한악안면성형재건외과학회지, 29(5), pp.456~462 (2007), 대한악안면성형재건외과학회
5. 박용덕, "한국인 치과의사의 비스포스포네이트 관련 악골괴사에 대한 인식 연구 : 예비보고", 대한구강악안면외과학회지, 35(3), pp.153~157 (2009), 대한구강악안면외과학회
6. Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update", J Oral Maxillofac Surg, 67(5), pp.2~12 (2009)
7. 대한내분비학회, "비스포스포네이트와 관련한 악골(턱뼈) 괴사", 대한내분비학회지, 24(4), pp.227~230 (2009), 대한내분비학회
8. Francis MD, "Diphosphonate inhibit formation of calcium phosphate crystals in vitro and pathological calcifications in vivo", Science, 165, pp.1264~1266 (1969)
9. van Beek E, "Farnesyl pyrophosphate synthase is the molecular target of nitrogen containing bisphosphonates", Biochem Biophys Res Commun, 264, pp.108~111 (1999)
10. Kimmel DB, "Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates", J Dent Res, 86, pp.1022~1033 (2007)
11. Vaananen HK, "The cell biology of osteoclast function", J Cell Sci, 113, pp.377~381 (2000)
12. Fantasia JE, "Bisphosphonates-what the dentist needs to know: practical consideration", J Oral Maxillofac Surg, 67(5), pp.53~60 (2009)
13. Hillner BE, "American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel", J Clin Oncol, 18, pp.1378~1391 (2000)
14. Mehrotra B, "Bisphosphonates-role in cancer therapies", J Oral Maxillofac Surg, 67(5), pp.19~26 (2009)
15. Landesberg R, "alternative indications for bisphosphonate therapy", J Oral Maxillofac Surg, 67(5), pp.27~34 (2009)
16. Allen MR, "The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data", J Oral Maxillofac Surg, 67(5), pp.61~70 (2009)
17. Russell RG, "Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy", Ann N Y Acad Sci, 1117, pp.209~257 (2007)
18. Garetto LP, "Remodeling dynamics of bone supporting rigidly fixed titanium implants: a histomorphometric comparison in four species including humans", Implant Dent, 4, pp.235~243 (1995)
19. Han ZH, "Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanism of bone loss", J Bone Miner Res, 12, pp.498~508 (1997)
20. Allen MR, "Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment", J Oral Maxillofac Surg, 66, pp.987~994 (2008)
21. Lewiecki EM, "Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD", J Bone Miner Res, 22, pp.1832~1841 (2007)
22. "J Oral Maxillofac Surg", 2007, 573~580
23. therapy, "Osteoporos Int", 2008, 80~
24. Wang HL, "Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report", J Periodontol, 78, pp.584~594 (2007)
25. Li C, "Longterm effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats", J Bone Miner Res, 16, pp.429~436 (2001)
26. Peter CP, "Effect of alendronate on fracture healing and bone remodeling in dogs", J Orthop Res, 14, pp.74~79 (1996)
27. Frost HM, "In vivo osteocyte death", J Bone Joint Surg Am, 42, pp.138~143 (1960)
28. Roelofs AJ, "Use of a fluorescent analogue of risedronate to study localisation and cellular uptake of bisphosphonates in vivo", Bone, 42(1), pp.85~ (2008)
29. Guise TA, "Antitumor effects of bisphosphonates: promising preclinical evidence", Cancer Treat Rev, 34(1), pp.19~24 (2008)
30. Lipton A, "Emerging role of bisphosphonates in the clinic-antitumor activity and prevention of metastasis to bone", Cancer Treat Rev, 34(1), pp.25~30 (2008)
31. Ruggiero SL, "Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases", J Oral Maxillofac Surg, 62, pp.527~534 (2004)
32. Wood J, "Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid", J Pharmacol Exp Ther, 302, pp.1055~1061 (2002)
33. Estilo CL, "Osteonecrosis of the jaw related to bevacizumab", J Clin Oncol, 26, pp.4037~4038 (2008)
34. Somerman MJ, "Bisphosphonates: sacrificing the jaw to save the skeleton?", Bonekey Osteovision, 3, pp.12~18 (2006)
35. Lurie AG, "99 M", Tc-diphosphonate bone imaging and uptake in healing rat extraction sockets, 1976, pp.17, 688~692
36. McDougall IR, "Skeletal scintigraphy", West J Med, 130, pp.503~514 (1979)
37. Hellstein JW, "Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?", J Oral Maxillofac Surg, 63, pp.682~689 (2005)
38. Hansen T, "Actinomycosis of the jaws-histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis", Virchows Arch, 451, pp.1009~1017 (2007)
39. Khamaisi M, "Possible association between diabetes and bisphosphonate-related jaw osteonecrosis", J Clin Endocrinol Metab, 92, pp.1172~1175 (2007)
40. Wessel JH, "Zoledronate, smoking and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study", J Oral Maxillofac Surg, 66, pp.625~631 (2008)
41. Bamias A, "Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors", J Clin Oncol, 23, pp.8580~8587 (2005)
42. Hoff AO, "Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy. ASCO Annual Meeting Proceedings (postmeeting edition)", J Clin Oncol, 24(18), pp.8528~ (2006)
43. Durie BG, "Osteonecrosis of the jaws and bisphosphonates", N Engl J Med, 353, pp.99~102 (2005)
44. Badros A, "Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors", J Clin Oncol, 24, pp.945~952 (2006)
45. Sarasquete ME, "Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis", Blood, 112, pp.2709~2712 (2008)
46. Krane SM, "Death and taxes: glucocorticoids and Bone Cell Apoptosis", BoneKEy-Osteovision, 1, pp.2001019~ (2001)
47. Ruggiero SL, "Osteonecrosis of the jaws and bisphosphonate therapy", J Dent Res, 86, pp.1013~1021 (2007)
48. Ruggiero SL, "Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 102, pp.433~441 (2006)
49. Arce K, "Imagind findings in bisphosphonate-related osteonecrosis of jaws", J Oral Maxillofac Surg, 67(5), pp.75~84 (2009)
50. Raje N, "Richardson PG, Vallet S, et al. Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw", Clin Cancer Res, 14, pp.2387~2395 (2008)
51. Marx RE, "Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment", J Oral Maxillofac Surg, 65, pp.2397~2410 (2007)
52. Kunchur R, "Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws", J Oral Maxillofac Surg, 68(2), pp.487~488 (2010)
53. Kos M, "Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk", J Craniomaxillofac Surg, 38, pp.255~259 (2010)
54. Madrid C, "What impact do systemically administratedbisphosphonates have on oral implant therapy? A systematic review", Clin Oral Implants Res, 20(4), pp.87~95 (2009)

관련 논문AI추천